Related Experiment Video
Updated: Jul 15, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Glycogen synthase kinase-3beta -- actively inhibiting hypertrophy
Risto Kerkelä1, Kathleen Woulfe, Thomas Force
1Center for Translational Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA.
Glycogen synthase kinase-3beta integrates signals regulating cardiac hypertrophy. This review explores its pivotal role in the heart's response to physiological and pathological growth stimuli.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Signaling
Background:
- Cardiac hypertrophy and remodeling involve complex signaling networks.
- Glycogen synthase kinase-3beta (GSK-3β) is a key protein kinase.
- GSK-3β acts as a central integrator and transducer in cellular signaling.
Purpose of the Study:
- To review the function of GSK-3β in cardiac adaptation.
- To elucidate GSK-3β's role in response to cardiac growth stimuli.
- To highlight GSK-3β as a nodal point in cardiac signaling.
Main Methods:
- Literature review of signaling pathways in cardiac hypertrophy.
- Analysis of GSK-3β's position within regulatory networks.
- Synthesis of data on GSK-3β's involvement in cardiac responses.
Main Results:
- GSK-3β integrates diverse upstream signals.
- GSK-3β transduces signals to downstream effectors.
- GSK-3β plays a critical role in both physiological and pathological cardiac growth.
Conclusions:
- GSK-3β is a crucial "nodal point" in cardiac hypertrophy.
- Understanding GSK-3β's role is vital for targeting cardiac remodeling.
- Further research into GSK-3β signaling may reveal therapeutic strategies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
TGF - β Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Cellular Adaptation II: Hypertrophy
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Enzymatic Cascade
